Delivery Order SPE2DE21D7010-SPE2D625F8WJ0
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, received a $15,686.10 delivery order award from the Defense Logistics Agency (DLA) Medical Supply Chain on June 17, 2025, for RELINE MAS implants. The contract utilizes a fixed-price structure with economic price adjustment provisions and has an ultimate completion date of June 18, 2025. This award was made without set-aside designation, reflecting Nuvasive's competitive success in open...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and implants, was awarded a $12.43K fixed-price delivery order with economic price adjustment for RELINE MAS IMPLANTS by the Defense Logistics Agency (DLA) Medical Supply Chain on September 9, 2025. The contract, with an ultimate completion date of October 3, 2025, carries no set-aside designation, indicating open market competition. Performance will take place in San Diego, California. This delivery...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, has been awarded a $39,829.90 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency. The contract, designated as RELINE-ONE, is structured as a fixed-price delivery order with economic price adjustment mechanisms and carries no set-aside designation, indicating open market competition. The place of performance is San Diego,...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, was awarded a $10,525.48 delivery order (RELINE-C) by the Defense Logistics Agency Medical Supply Chain on May 30, 2025. The contract utilizes a fixed-price with economic price adjustment pricing structure and carries no set-aside designation, indicating competitive open-market procurement. Performance is scheduled to conclude by June 20, 2025, at the company's San Diego, California location. This...
- Nuvasive, Inc. was awarded a delivery order valued at $12,607.94 by the Defense Logistics Agency Medical Supply Chain on June 26, 2025, for the procurement of RELINE open implants. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by July 17, 2025, and will be performed at Nuvasive's San Diego, California location. This award was made through open competition with no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc. was awarded a $71,959.93 fixed-price delivery order (4568882953, RELINE-ONE) by the Defense Logistics Agency Medical Supply Chain on July 24, 2025, with an ultimate completion date of August 13, 2025. The contract, which carries no set-aside designation, will be performed in San Diego, California. This delivery order is issued under Nuvasive's existing indefinite delivery/indefinite quantity (IDIQ) contract vehicle, likely the $8 million Blanket Purchase Agreement with the Defense...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $1,681.90 by the Defense Logistics Agency (DLA) Medical Supply Chain on July 24, 2025. This fixed-price contract with economic price adjustment mechanisms is set to be completed by July 25, 2025. The award represents an open market procurement with no set-aside designation, consistent with Nuvasive's established competitive success in federal healthcare...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 on May 28, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as delivery order 4568393753 for the SMALL INTERLOCK II product, is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of June 17, 2025. This award was made without any set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025. The contract, designated as "SMALL INTERLOCK II," represents a fixed-price delivery order with economic price adjustment mechanisms and carries an ultimate completion date of September 22, 2025. The award was made without any set-aside designation,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and services, received a delivery order award valued at $1,850.60 from the Defense Logistics Agency (DLA) Medical Supply Chain on July 17, 2025. The contract, designated as a fixed-price agreement with economic price adjustment mechanisms, carries an ultimate completion date of August 6, 2025. This award was issued without set-aside designation, indicating open market competition. The delivery...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D625F8WJ0Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $47,148.17 for RELINE MAS IMPLANTS on July 22, 2025. The contract utilizes a fixed-price with economic price adjustment pricing structure and carries no set-aside designation, indicating open market competition. The work will be performed in San Diego, California, with an ultimate completion date of August 15, 2025. This delivery order is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal entity responsible for supplying medical products to Department of Defense and Department of Veterans Affairs healthcare facilities. This award is likely issued under Nuvasive's existing $8 million Blanket Purchase Agreement with the Defense Health Agency, which serves as an Indefinite Delivery/Indefinite Quantity vehicle through March 2027, or a related Defense Logistics Agency contract vehicle. Nuvasive's parent company, Transplant Technology Inc., operates the Bone Bank Allografts division and maintains significant federal contracts for advanced orthopedic and spinal surgical technologies. The company has demonstrated consistent success in delivering specialized medical implants and instruments to support complex surgical procedures across military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.1k | 7/22/25 |